Are you Dr. Hecht?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 27 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9440 Sw 91st St
Miami, FL 33176Phone+1 305-271-0099Fax+1 305-667-0239- Is this information wrong?
Summary
- Dr. Sidney Hecht, MD is a board certified nuclear medicine physician in Miami, Florida. He is currently licensed to practice medicine in Florida.
Education & Training
University of Miami/Jackson Health SystemResidency, Radiology-Diagnostic, 1971 - 1975- University of Miami/Jackson Health SystemInternship, Internal Medicine, 1970 - 1971
University of Miami Leonard M. Miller School of MedicineClass of 1970
Certifications & Licensure
FL State Medical License 1973 - 2025- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- 1 citationsChemical synthesis of lipophilic methylene blue analogues which increase mitochondrial biogenesis and frataxin levels.Indrajit Bandyopadhyay, Sandipan Roy Chowdhury, Nishant P. Visavadiya, Sidney M. Hecht, Omar M. Khdour> ;Data in Brief. 2018 Aug 31
- 7 citationsLipophilic methylene blue analogues enhance mitochondrial function and increase frataxin levels in a cellular model of Friedreich's ataxia.Omar M. Khdour, Indrajit Bandyopadhyay, Sandipan Roy Chowdhury, Nishant P. Visavadiya, Sidney M. Hecht> ;Bioorganic & Medicinal Chemistry. 2018 Jul 23
- 14 citationsOligomeric amyloid β preferentially targets neuronal and not glial mitochondrial-encoded mRNAsDiego Mastroeni, Jennifer Nolz, Omar M. Khdour, Shobana Sekar, Elaine Delvaux, Lori Cuyugan, Winnie S. Liang, Sidney M. Hecht, Paul D. Coleman> ;Alzheimer's & Dementia. 2018 Jun 1
- Join now to see all
Grant Support
- Synthesis Of Bleomycin Group Antibiotics And AnaloguesNational Cancer Institute1998–2007
- Elaboration Of Modified Proteins Using Misacylated TrnasNational Cancer Institute1998–2007
- Interaction Of Bleomycin With RNA And DNANational Cancer Institute1998–2006
- Natural Products Discovery - Nuclear And Signaling TargeNational Cancer Institute2000–2004
- Mechanism And Inhibition Of Human DNA Topoisomerase INational Cancer Institute2000–2003
- Nuclear Targets For Natural Products Drug DiscoveryNational Cancer Institute1995–2002
- Core--Preparation, Storage, And Shipping Of Plant Extracts And AssaysNational Cancer Institute1995–2002
- Natural Products Discovery--Nuclear &Signaling TargetsNational Cancer Institute1995–2000
- Natural Prod Discovery--Nuclear &Signaling TargetsNational Cancer Institute1999
- Nucleic Acids As Therapeutic TargetsNational Cancer Institute1991–1997
- Nucleic Acids As Therapeutic Targets: Bleomycin, Antitumor, AntibioticNational Center For Research Resources1996
- Synthesis/Inhibition--P Falciparum DNA Polymerase DeltaNational Institute Of Allergy And Infectious Diseases1995
- Mechanism Based Discovery Of Novel Antitumor AgentsNational Cancer Institute1994
- Synthetic Polypeptides VIA In Vitro Protein BiosynthesisNational Institute Of General Medical Sciences1990–1994
- Dept Chemistry, University Of VirginiaNational Cancer Institute1989–1994
- Mechanism-Based Discovery Of Novel Antitumor AgentsNational Cancer Institute1989–1993
- Chemistry Of Activated BleomycinNational Cancer Institute1988–1991
- Synthesis Of Bleomycin Group AntibioticsNational Cancer Institute1985–1991
- Inhibition Of HIV ExpressionNational Institute Of Allergy And Infectious Diseases1988–1990
- Natural Products That Cleave DNANational Cancer Institute1985–1990
- Purchase Of General Electric Gn-500 NMR SpectrometerNational Center For Research Resources1988
- Nucleotide Replacements In Transfer RNANational Institute Of General Medical Sciences1985–1987
- Chemistry Of Activated BleomycinNational Cancer Institute1985–1987
- Purchase Of Varian Xl-300 NMR SpectrometerNational Center For Research Resources1986
